Inability of Plasma and Urine F2A-Isoprostane Levels to Differentiate Mild Cognitive Impairment from Alzheimer's Disease

Por Mufson, Elliott J., Leurgans, Sue
Publicado em 2010

Noradrenaline activation of neurotrophic pathways protects against neuronal amyloid toxicity

Por Counts, Scott E., Mufson, Elliott J.
Publicado em 2010

PUTATIVE CSF PROTEIN BIOMARKER CANDIDATES FOR AMNESTIC MILD COGNITIVE IMPAIRMENT

Por Counts, Scott E., Mufson, Elliott J.
Publicado em 2010

Regulator of Cell Cycle (RGCC) Expression during the Progression of Alzheimer's Disease

Por Counts, Scott E., Mufson, Elliott J.
Publicado no Cell Transplant (2017)

Prefibrillar Tau Oligomers in MCI and Alzheimer Disease

Por Mufson, Elliott J., Ward, Sarah, Binder, Lester
Publicado em 2013

A novel approach for long-term oral drug administration in animal research

Por Overk, Cassia R., Borgia, Jeffrey A., Mufson, Elliott J.
Publicado em 2010

Brainstem Alzheimer’s-Like Pathology in the Triple Transgenic Mouse Model of Alzheimer’s Disease

Por Overk, Cassia R., Kelley, Christy M., Mufson, Elliott J.
Publicado em 2009

Evidence for a neuroprotective microRNA pathway in amnestic mild cognitive impairment

Por Weinberg, Rebecca B., Mufson, Elliott J., Counts, Scott E.
Publicado no Front Neurosci (2015)

Oxidative stress and hippocampal synaptic protein levels in elderly cognitively intact individuals with Alzheimer's disease pathology

Por Scheff, Stephen W., Ansari, Mubeen A., Mufson, Elliott J.
Publicado no Neurobiol Aging (2016)

Preservation of cortical sortilin protein levels in MCI and Alzheimer’s disease

Por Mufson, Elliott J., Wuu, Joanne, Counts, Scott E., Nykjaer, Anders
Publicado em 2010

Increased Matrix Metalloproteinase-9 Activity in Mild Cognitive Impairment

Por Bruno, Martin A., Mufson, Elliott J., Wuu, Joanne, Cuello, A. Claudio
Publicado em 2009

Gender differences in NGF receptor expression in cholinergic nucleus basalis neurons during the progression of Alzheimer’s disease

Por Counts, Scott E., Che, Shaoli, Ginsberg, Stephen D., Mufson, Elliott J.
Publicado em 2011

Single cell gene expression profiling in Alzheimer’s disease

Por Ginsberg, Stephen D., Che, Shaoli, Counts, Scott E., Mufson, Elliott J.
Publicado em 2012

Braak staging, plaque pathology and APOE status in elderly persons without cognitive impairment

Por Mufson, Elliott J., Malek-Ahmadi, Michael, Perez, Sylvia E., Chen, Kewei
Publicado no Neurobiol Aging (2015)

Cholinergic system during the progression of Alzheimer's disease: therapeutic implications

Por Mufson, Elliott J, Counts, Scott E, Perez, Sylvia E, Ginsberg, Stephen D
Publicado em 2008

Neuroprotective Role for Galanin in Alzheimer’s Disease

Por Counts, Scott E., Perez, Sylvia E., Ginsberg, Stephen D., Mufson, Elliott J.
Publicado em 2010

β-Amyloid Deposition and Functional Impairment in the Retina of the APPswe/PS1ΔE9 Transgenic Mouse Model of Alzheimer’s Disease

Por Perez, Sylvia E., Lumayag, Stephen, Kovacs, Beatrix, Mufson, Elliott J., Xu, Shunbin
Publicado em 2008

Galanin Hyperinnervation Upregulates Choline Acetyltransferase Expression in Cholinergic Basal Forebrain Neurons in Alzheimer's Disease

Por Counts, Scott E., He, Bin, Che, Shaoli, Ginsberg, Stephen D., Mufson, Elliott J.
Publicado em 2008

Galanin Fiber Hyperinnervation Preserves Neuroprotective Gene Expression in Cholinergic Basal Forebrain Neurons in Alzheimer’s Disease

Por Counts, Scott E., He, Bin, Che, Shaoli, Ginsberg, Stephen D., Mufson, Elliott J.
Publicado em 2009

Effect of Neocortical and Hippocampal Amyloid Deposition upon Galaninergic and Cholinergic Neurites in AβPPswe/PS1ΔE9 Mice

Por Kelley, Christy M., Perez, Sylvia E., Overk, Cassia, Wynick, David, Mufson, Elliott J.
Publicado em 2011